Applied DNA Sciences Incの業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2022年9月
|
18
|
-14
|
-9
|
-9
|
13
|
5
|
12
|
9
|
22
|
15
|
|
19
|
4
|
-293
|
-76.89%
|
-45.52%
|
-45.51%
|
57.99%
|
-9
|
-1
|
18
|
-49.41%
|
-10
|
-68.83%
|
-45.08%
|
-0.00000093
|
-0.00000093
|
|
2021年9月
|
9
|
-14
|
-15
|
-15
|
|
|
11
|
3
|
14
|
6
|
|
11
|
3
|
-285
|
-145.26%
|
-158.16%
|
-158.16%
|
77.09%
|
-14
|
-3
|
14
|
-148.3%
|
-16
|
-169.66%
|
-110.87%
|
-0.00000207
|
-0.00000207
|
|
2020年9月
|
1
|
-13
|
-14
|
-14
|
0
|
1
|
5
|
5
|
11
|
7
|
|
9
|
4
|
-270
|
-648.98%
|
-674.55%
|
-674.46%
|
50.42%
|
-12
|
-2
|
19
|
-576.91%
|
-13
|
-534.26%
|
-174.79%
|
|
|
|
2019年9月
|
5
|
-10
|
-9
|
-9
|
0
|
4
|
-1
|
4
|
3
|
0
|
|
2
|
2
|
-257
|
-169.31%
|
-159.91%
|
-160.01%
|
-23.61%
|
-7
|
-1
|
5
|
-127.33%
|
-7
|
19833.3%
|
-187.49%
|
|
|
|
2018年9月
|
|
-12
|
-12
|
-12
|
1
|
|
0
|
|
5
|
1
|
|
4
|
2
|
-249
|
|
|
|
|
-7
|
-1
|
5
|
|
|
|
|
|
|
|
2017年9月
|
4
|
-13
|
-13
|
-13
|
1
|
3
|
6
|
1
|
8
|
2
|
|
6
|
1
|
-237
|
-269.83%
|
-270.58%
|
-270.58%
|
84.11%
|
-8
|
-1
|
6
|
-157.41%
|
-8
|
-149.24%
|
-108.38%
|
|
|
|
2016年9月
|
4
|
-13
|
|
-13
|
|
|
10
|
5
|
15
|
|
|
|
|
|
-291.17%
|
0.0%
|
-290.69%
|
66.6%
|
-10
|
-1
|
7
|
-236.28%
|
-11
|
-106.19%
|
-78.28%
|
|
|
|
2015年9月
|
9
|
-8
|
|
-12
|
|
|
12
|
2
|
15
|
|
|
|
|
|
-87.13%
|
0.0%
|
-131.85%
|
80.84%
|
-7
|
-3
|
15
|
-77.36%
|
-10
|
-214.05%
|
-124.66%
|
|
|
|
2014年9月
|
2
|
-13
|
|
-14
|
|
|
-2
|
4
|
3
|
|
|
|
|
|
-451.1%
|
0.0%
|
-480.51%
|
-41.88%
|
-9
|
-1
|
3
|
-312.87%
|
-9
|
-829.84%
|
-220.03%
|
|
|
|
2013年9月
|
2
|
-11
|
|
-18
|
|
|
4
|
3
|
8
|
|
|
|
|
|
-499.02%
|
0.0%
|
-867.16%
|
55.2%
|
-8
|
-2
|
14
|
-385.78%
|
-10
|
|
|
|
|
|
2011年9月
|
0
|
-9
|
-11
|
-11
|
|
|
-1
|
4
|
3
|
2
|
|
3
|
4
|
-162
|
-831.55%
|
-1085.32%
|
-1085.32%
|
-28.41%
|
-4
|
-1
|
6
|
-388.27%
|
-4
|
|
|
|
|
|